Heart Failure

Results of an analysis incorporating data on more than 29,000 patients concluded consuming 2 or more servings of meat per week increased risk of cardiovascular disease.

A meta-analysis of CREDENCE, DECLARE-TIMI 58, CANVAS, and EMPA-REG OUTCOME trial is revealing more about how SGLT2 inhibition impacts different subgroups of diabetics.

An analysis of the Southern Community Cohort Study found differences in the impact of modifiable risk factors for heart failure among black and white patients.

An oral tablet combining empagliflozin, linagliptin, metformin hydrochloride will soon be available on US markets.

New data from the Annual Meeting of the Society of Thoracic Surgeons reveals a three-day stay is not associated with increased risk of worse outcomes or readmission.

A new analysis of more than 125,000 found no differences in mortality or MACE based on type of insulin used.

New data suggests sacubitril/valsartan could reduce risk of hospitalization and mortality in HFrEF patients when compared with ACEs/ARBs.

A new review in the Journal of the American College of Cardiology is highlighting the impact of marijuana use on heart health.

New research suggests Abbott's HeartMate 3 could revolutionize preimplantation strategy by eliminating use of categories based on transplant eligibility.

Less than 1 in 4 eligible Medicare patients attend a cardiac rehabilitation program and, among participants, adherence to programs remains an issue.

An analysis of more than 9000 patients found incident heart disease was associated with an increased risk of developing kidney failure later in life.

A recent study found a lower blood pressure target in older adults could reduce risk of cardiovascular events and death, but could negatively impact kidney function.

Abbot announced early Tuesday morning that the US FDA has granted approval for the HeartMate 3 device to be implanted via a lateral thoracotomy for patients with advanced heart failure.

A study from investigators at UCLA has identified a biomarker investigators suggest can help identify stable heart failure patients at an increased risk of death within the next 3 years.

Increased levels of pyrethroid insecticide exposure was linked to increased in all-cause mortality, as well as increases in mortality from cancer and cardiovascular disease in a recent study from the University of Iowa.

A recent study from the Mayo Clinic of Rochester, MN is suggested diabetes mellitus is an independent risk factor for the development of heart failure.

How the two critical specialties become better bridged at medical meetings?

How women who undergo menopause before age 40 may be at a greater risk of heart disease.

How technology, innovation, and preventive care drove the last 10 years of improved public heart health.

A discussion on why heart failure rates have climbed over the past decade while research indicates rates of cardiovascular disease, as a whole, have begun to decline.

Evaluating the impact of DAPA-HF and other recent data that have changed the way cardiologists view the potential uses of SGLT2 inhibitors in patients with or without diabetes.

A new analysis from the University of Minnesota has found many patients with and without an indication for regular low dose aspirin use are under or overusing the medication.

Why US patients are now in absolute need of proven measures to lessen their risk of cardiovascular burden.

What more needs to be learned about the link between the 2 diseases?

A conversation with Deepak Bhatt, MD, MPH, discussing the most impactful advances in cardiology in 2019 and what he sees as the most important advances in the past decade as 2019 comes to a close.